Meneses, G. (2021). Commentary about open-label randomized controlled study of ivermectin in mild to moderate COVID-19. IMC Journal of Medical Science, 14(2), 67–68. Retrieved from https://banglajol.info/index.php/IMCJMS/article/view/52833